Breaking News

LabVantage Launches Biobanking LIMS Accelerator for Managing COVID-19 Testing

Comes pre-configured and requires no infrastructure investment

By: Contract Pharma

Contract Pharma Staff

LabVantage Solutions, Inc., a provider of laboratory informatics solutions and services, has announced the availability of its purpose-built COVID-19 LIMS solution. The new solution is designed to jump-start the ability of laboratories everywhere to enter biospecimens into a biobank and rapidly begin conducting COVID-19-related testing and research. The LabVantage COVID-19 Biobanking Accelerator is built on the company’s LIMS and Biobanking platforms used by clinical laboratories around the glob...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters